Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study

BACKGROUND: Patients with colorectal metastatic disease have a poor prognosis, limited therapeutic options, and frequent development of resistance. Strategies based on tumor-derived organoids are a powerful tool to assess drug sensitivity at an individual level and to suggest new treatment options o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Lars Henrik, Rogatto, Silvia Regina, Lindebjerg, Jan, Havelund, Birgitte, Abildgaard, Cecilie, do Canto, Luisa Matos, Vagn-Hansen, Chris, Dam, Claus, Rafaelsen, Søren, Hansen, Torben Frøstrup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161587/
https://www.ncbi.nlm.nih.gov/pubmed/37143108
http://dx.doi.org/10.1186/s13046-023-02683-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161587/
https://www.ncbi.nlm.nih.gov/pubmed/37143108
http://dx.doi.org/10.1186/s13046-023-02683-4

Ejemplares similares